Next Edge Capital Corp. ("Next Edge" or the "Manager") announced that a preliminary prospectus for CMP Next Edge 2025 Critical and Precious Metals Short Duration Flow-Through Limited Partnership (the ...

WuXi Biologics is giving CDMO Terumo the keys to its site in Leverkusen, Germany, with a 150 million euros ($167 million) sale. With the deal, WuXi Biologics can “exclusivity focus” on ...

As per the latest analysis, the biosimilar and biologics market value is estimated to reach USD 520.9 billion in 2024. Global sales of biosimilars and biologics will likely increase at 7.6% CAGR ...

Stock Repurchase Program: Authorized up to $500 million. ADMA Biologics Inc (NASDAQ:ADMA) reported a 40% year-over-year increase in total revenues for Q1 2025, reaching $114.8 million. The company ...

Investment Activities: Net $17 million, mostly in property, plant, and equipment. AbCellera Biologics Inc (NASDAQ:ABCL) is advancing its first-in-class therapeutic antibody, ABCL635, for non ...

Y-Biologics, a company specializing in antibody drugs, announced on the 13th that it has signed a new antibody technology transfer agreement with LigaChem Biosciences to develop next-generation ...

SEATTLE & MILAN--(BUSINESS WIRE)--AGC Biologics, your friendly CDMO expert, today announced a partnership with Quell Therapeutics (“Quell”), a clinical-stage biotechnology company pioneering ...

EDISON, N.J. & SALT LAKE CITY--(BUSINESS WIRE)--MTF Biologics, a global nonprofit organization that saves and heals lives by advancing tissue and organ donation, transplantation, and research ...

SAN DIEGO — Disease-modifying antirheumatic drugs (DMARDs) and biologics were linked to as much as a 74.5% reduction in the risk for alopecia areata (AA) in patients with psoriasis, a new ...

Despite securing a much-needed $5 million lifeline from an equity offering this week, HCW Biologics is continuing to warn that its financial future remains in doubt. The inflammation-focused ...